The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Human Hypertension

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/jhh.2011.29PMID 21451568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre-eclampsia

  2012cited by this paper
• Role of Endothelin in Mediating Soluble fms-Like Tyrosine Kinase 1–Induced Hypertension in Pregnant Rats

  2010cited by this paper
• Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction.

  2010cited by this paper
• Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy

  2010cited by this paper
• Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression

  2009cited by this paper
• Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype

  2009cited by this paper
• Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats.

  2009cited by this paper
• Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.

  2008cited by this paper
• Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension.

  2008cited by this paper
• Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.

  2008cited by this paper
• Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells.

  2008cited by this paper
• Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia?

  2007cited by this paper
• Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression

  2007cited by this paper
• Soluble endoglin contributes to the pathogenesis of preeclampsia

  2006cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• Enhanced Endothelin Synthesis by Endothelial Cells Exposed to Sera From Pregnant Rats With Decreased Uterine Perfusion

  2006cited by this paper
• Circulating Angiogenic Factors and the Risk of Preeclampsia

  2005cited by this paper
• Mechanisms of Disease: pre-eclampsia

  2005cited by this paper
• Pre-eclampsia

  2005cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) could contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

  2003cited by this paper
• Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria*

  2003cited by this paper
• Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.

  2003cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• Endothelin Type A Receptor Blockade Attenuates the Hypertension in Response to Chronic Reductions in Uterine Perfusion Pressure

  2001cited by this paper
• Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction.

  2001cited by this paper
• Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy

  2001cited by this paper
• Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia.

  2000cited by this paper
• Nitric oxide and pregnancy.

  1997cited by this paper
• Nitric oxide-mediated vasodilation in human pregnancy.

  1997cited by this paper
• Choriodecidual production of interleukin‐8 and mechanism of parturition

  1992cited by this paper
• Endothelin, elastase, and endothelial dysfunction in pre-eclampsia.

  1991cited by this paper
• Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies.

  1990cited by this paper

• Plasma Extracellular Vesicles from Preeclamptic Patients Trigger a Detrimental Crosstalk Between Glomerular Endothelial Cells and Podocytes Involving Endothelin-1

  2025cites this paper
• Sphingosine-1-Phosphate, a Marker of Endothelial Injury and Disease Severity in Preeclampsia

  2025cites this paper
• The multifactorial role of HDAC9 at the maternal–fetal interface in the pathogenesis of preeclampsia

  2025cites this paper
• Studying serum level of soluble endoglin in preeclamptic women

  2025cites this paper
• sFlt-1/PlGF and beyond: angiolymphatic-associated signatures and emerging biomarkers in placental pathology

  2025cites this paper
• Targeting IL6-Edn1-FoxO1 axis enables lung growth in mechanically ventilated newborn mice

  2025cites this paper
• Endothelin-1 and Thyroid Hormone Dysregulation: Potential Biomarkers for Early Detection of Pre-Eclampsia

  2025cites this paper
• Low-Molecular-Weight Heparin in Preeclampsia: Effects on Biomarkers and Prevention: A Narrative Review

  2025influential citation
• Localization and quantification of HDAC9 and RGS2 expression in placenta during preeclampsia.

  2025cites this paper
• The Research Progress of DNA Methylation in the Development and Function of the Porcine Placenta

  2024cites this paper
• Placental and Renal Pathways Underlying Pre-Eclampsia

  2024cites this paper
• Maternal Microvascular Dysfunction During and After Preeclamptic Pregnancy.

  2024cites this paper
• Neurodevelopmental Disruptions in Children of Preeclamptic Mothers: Pathophysiological Mechanisms and Consequences

  2024cites this paper
• Prediction of adverse outcome by ophthalmic artery Doppler and angiogenic markers in pregnancies with new onset hypertension.

  2023cites this paper
• Endothelin-1 Level In Early Onset Preeclampsia

  2023influential citation
• Mitochondrial-targeted antioxidant attenuates preeclampsia-like phenotypes induced by syncytiotrophoblast-specific Gαq signaling

  2023cites this paper
• Role of leptin in the pathophysiology of preeclampsia.

  2023cites this paper
• From Biomarkers to the Molecular Mechanism of Preeclampsia—A Comprehensive Literature Review

  2023cites this paper
• Machine learning-based protein signatures for differentiating hypertensive disorders of pregnancy

  2023cites this paper
• Endothelin-1 production via placental (pro)renin receptor in a mouse model of preeclampsia.

  2023cites this paper
• Dietary supplements and vascular function in hypertensive disorders of pregnancy

  2023cites this paper
• Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections

  2022cites this paper
• Endothelial dysfunction in preterm infants: The hidden legacy of uteroplacental pathologies

  2022cites this paper
• Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries—A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development

  2022cites this paper
• Maternal Serum Soluble Endoglin Levels as a biomarker in Preeclampsia: A Case Control Tertiary Care Hospital Based Study

  2022cites this paper
• Statins in Pregnancy: Can We Justify Early Treatment of Reproductive Aged Women?

  2022cites this paper
• Prediction of preeclampsia based on maternal serum endoglin level in women with pregestational diabetes mellitus

  2022cites this paper
• Expression of Endothelin-1 and Endothelial Nitric Oxide Synthase in Normal and Preeclamptic Placentae

  2022cites this paper
• Hyperlipidemia and risk for preclampsia.

  2022cites this paper
• Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia

  2021cites this paper
• Endothelial Dysfunction in Pregnancy Complications

  2021cites this paper
• Preeclampsia: inflammatory signature of decidual cells in early manifestation of disease.

  2021cites this paper
• Vascular Dysfunction in Preeclampsia

  2021cites this paper
• Correlation between maternal variables and the onset and severity of preeclampsia

  2021cites this paper
• Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine

  2021cites this paper
• Prenatal endothelin or thromboxane receptor antagonism surpasses sympathoinhibition in improving cardiorenal malfunctions in preeclamptic rats.

  2021cites this paper
• Transforming growth factor-beta and liver injury in an arginine vasopressin-induced pregnant rat model

  2021cites this paper
• Interleukin-17 Signaling Mediates Cytolytic Natural Killer Cell Activation in Response to Placental Ischemia.

  2020cites this paper
• MODERN METHODS OF TREATMENT OF ACUTE RESPIRATORY INFECTIONS IN PREGNANT WOMEN

  2020cites this paper
• Adaptations in autonomic nervous system regulation in normal and hypertensive pregnancy.

  2020cites this paper
• Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

  2020cites this paper
• Evaluation of maternal plasma platelet activating factor acetylhydrolase activity and mRNA expression in pre-eclampsia: a case control study

  2020cites this paper
• Quercetin attenuates reduced uterine perfusion pressure -induced hypertension in pregnant rats through regulation of endothelin-1 and endothelin-1 type A receptor

  2020cites this paper
• The prediction of early preeclampsia: Results from a longitudinal proteomics study

  2019cites this paper
• Targeting the vascular dysfunction: Potential treatments for preeclampsia

  2019cites this paper
• Maternal Serum sEndoglin and Cell-Free Fetal DNA as Probable Markers of Preeclampsia: A Study in Single Center, Egypt

  2019cites this paper
• VEGF and sFLT-1 in serum of PIH patients and effects on the foetus

  2019cites this paper
• Immunohistochemical Features of Endothelin-Producing Activity of the Ovaries Vascular Component in Fetuses from Mothers with Pregnancy Complicated by Pre-Eclampsy of Varying Severity

  2019cites this paper
• The Preeclampsia intervention with Esomeprazole (PIE) trial: A double blind, randomised, placebo-controlled trial to treat early onset severe preeclampsia

  2019cites this paper
• Endothelin receptor antagonism during preeclampsia: a matter of timing?

  2019cites this paper
• Endothelin-1 profiles in advanced maternal age complicated with hypertensive disorders of pregnancy.

  2019cites this paper
• HIF-1α regulates angiogenesis via Notch1/STAT3/ETBR pathway in trophoblastic cells

  2019cites this paper
• Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia

  2019cites this paper
• Transfer and Vascular Effect of Endothelin Receptor Antagonists in the Human Placenta

  2019cites this paper
• Thrombocytopenia in Pregnancy

  2019cites this paper
• Serum endothelin-1 and placental alkaline phosphatase levels in placenta percreta and normal pregnancies

  2018cites this paper
• Factores anti-angiogénicos y preeclampsia

  2018cites this paper
• Preeclampsia biomarkers: An assessment of maternal cardiometabolic health.

  2018cites this paper
• Amperometric determination of endoglin in human serum using disposable immunosensors constructed with poly(pyrrolepropionic) acid-modified electrodes

  2018cites this paper
• Sex-Specific Contributions of Endothelin to Hypertension

  2018cites this paper
• The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia

  2018cites this paper
• Renin-Angiotensin-Aldosterone System in the Pathogenesis of Pregnancy-Induced Hypertension

  2018cites this paper
• Abnormal expression of microRNA-370 regulates Endoglin expression in preeclampsia

  2017cites this paper
• Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia.

  2017cites this paper
• B7‐33 replicates the vasoprotective functions of human relaxin‐2 (serelaxin)

  2017cites this paper
• Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia?

  2017cites this paper
• Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity

  2017cites this paper
• Impaired neurovascular reactivity in the microvasculature of pregnant women with preeclampsia

  2017cites this paper
• Relaxin treatment reduces angiotensin II-induced vasoconstriction in pregnancy and protects against endothelial dysfunction

  2017cites this paper
• Changes of platelet parameters in early severe preeclampsia.

  2017cites this paper
• Endothelial Factors in The Pathogenesis and Treatment of Chronic Kidney Disease Part II: Role in Disease Conditions. A Joint Consensus Statement from the ESH Working Group on Endothelin and Endothelial Factors And The Japanese Society of Hypertension

  2017cites this paper
• Angiogenic and antiangiogenic factors in preeclampsia.

  2017cites this paper
• DNA methylation-mediated silencing of FLT1 in parthenogenetic porcine placentas.

  2017cites this paper
• Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension

  2017cites this paper
• Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

  2016cites this paper
• Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1

  2016cites this paper
• Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females.

  2016cites this paper
• Endocrine regulation of maternal vascular adaptations to pregnancy

  2016cites this paper
• The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

  2016influential citation
• Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia

  2016cites this paper
• Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy

  2016cites this paper
• Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment

  2016cites this paper
• Molecular mechanisms of maternal vascular dysfunction in preeclampsia.

  2015cites this paper
• Correlation between fms-Like Tyrosine Kinase-1 (sFlt-1) Cell-Free Messenger RNA Expression and fms-Like Tyrosine Kinase-1 (sFlt-1) Protein Level in Severe Preeclampsia and Normal Pregnancy

  2015cites this paper
• Síndrome HELLP en embarazos pretérmino: evidencia fisiopatológica para uso de corticoides anteparto

  2015cites this paper
• Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.

  2015cites this paper
• Identification of a Novel Agonist-Like Autoantibody in Preeclamptic Patients.

  2015cites this paper
• Genome-Wide Transcriptome Directed Pathway Analysis of Maternal Pre-Eclampsia Susceptibility Genes

  2015cites this paper
• Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy

  2015cites this paper
• Angiogenic biomarkers in pregnancy: defining maternal and fetal health

  2015cites this paper
• Special Issue: Nurturing the Next Generation

  2015cites this paper
• ACE2 activation by xanthenone prevents leptin-induced increases in blood pressure and proteinuria during pregnancy in Sprague-Dawley rats.

  2014cites this paper
• Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome

  2014cites this paper
• Modelling aspects of preeclampsia in vitro and in vivo

  2014cites this paper
• Vascular Dysfunction in Preeclampsia

  2014influential citation
• Role of endothelin in uteroplacental circulation and fetal vascular function.

  2013cites this paper
• Vascular responses within and remote from pregnancy

  2013cites this paper
• Gestational Hypoxia Induces Preeclampsia-Like Symptoms via Heightened Endothelin-1 Signaling in Pregnant Rats

  2013cites this paper
• Angiogenic Factors Serum Level Variations in Pregnancy with Chronic Arterial Hypertension

  2013cites this paper
• Review: Potential druggable targets for the treatment of early onset preeclampsia.

  2013cites this paper